Free Newsletter
Phase Forward to buy Covance; ePro goes to Japan
> Data management solutions provider Phase Forward has agreed to purchase the Interactive Voice & Web Response Services (IVRS/IWRS) business of Covance in a deal that includes the marketing of Phase Forward's InForm electronic data capture solution and Clarix interactive response technology solution to Covance clients. Release
> Japanese CRO CMIC Co. and ePro solutions provider PHT Corp. are collaborating on a consolidated service network incorporating ePro for Japanese drug makers conducting clinical trials. Release
> Velos, a clinical research management systems provider, has announced updates to its eResearch platform that aid the cancer researchers in fulfilling new registration requirements for the U.S. National Cancer Institute's clinical trials reporting program. Announcement
> ICON of Dublin, a provider of outsourced development services, has acquired Veeda Labs, which offers biomarker lab services. ICON release
> Privately held Sorrento Therapeutics, developer of a platform technology for generating human monoclonal antibodies, has signed a merger agreement with publicly traded QuikByte Software in which Sorrento becomes a subsidiary of QuikByte, which has no active operations. Announcement
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




